| Income Statement |
| Total Revenue | 1.81M |
|
| Revenues (USD) | 1.81M |
| Gross Profit | 1.81M |
| Operating Expenses | 4.36M |
| Research and Development Expense | 446.42K |
| Selling, General and Administrative Expense | 3.91M |
| Operating Income | -2.55M |
| Net Income | -2.17M |
| Net Income Common Stock | -2.17M |
| Net Income Common Stock (USD) | -2.17M |
| Consolidated Income | -2.47M |
| Net Income to Non-Controlling Interests | -301.72K |
| Earnings per Basic Share | -0.25 |
| Earnings per Basic Share (USD) | -0.25 |
| Earnings per Diluted Share | -0.25 |
| Earning Before Interest & Taxes (EBIT) | -2.17M |
| Earning Before Interest & Taxes (USD) | -2.17M |
| Weighted Average Shares | 8.65M |
| Weighted Average Shares Diluted | 8.65M |
| Balance Sheet |
| Cash and Equivalents | 1.51M |
| Cash and Equivalents (USD) | 1.51M |
| Investments | 13.20M |
| Investments Current | 10.30M |
| Investments Non-Current | 2.90M |
| Trade and Non-Trade Receivables | 80.50K |
| Current Assets | 12.16M |
| Property, Plant & Equipment Net | 90.39K |
| Total Assets | 15.82M |
| Current Liabilities | 569.31K |
| Total Liabilities | 569.31K |
| Accumulated Retained Earnings (Deficit) | -14.87M |
| Accumulated Other Comprehensive Income | -358.11K |
| Shareholders Equity | 15.94M |
| Shareholders Equity (USD) | 15.94M |
| Assets Non-Current | 3.66M |
| Deferred Revenue | 242.31K |
| Goodwill and Intangible Assets | 673.43K |
| Trade and Non-Trade Payables | 228.04K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 60.56K |
| Net Cash Flow from Financing | 5.32M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 672.75K |
| Capital Expenditure | -2.65K |
| Issuance (Purchase) of Equity Shares | 5.32M |
| Net Cash Flow from Investing | -2.15M |
| Net Cash Flow - Investment Acquisitions and Disposals | -2.15M |
| Net Cash Flow from Operations | -2.49M |
| Share Based Compensation | 53.87K |